Clinical trials
Enrolling by invitation Carcinoma, Non-Small-Cell Lung trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Chest Hospital | 2 |
| Avistone Biotechnology Co., Ltd. | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Fujian Cancer Hospital | 1 |
| Henan Cancer Hospital | 1 |
| Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 1 |
| Man Hu | 1 |
| Ming Yang | 1 |
| Peking University Third Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 13 |
| Brain Neoplasms | 1 |
| Disease Progression | 1 |
| Esophageal Neoplasms | 1 |
| Glioblastoma | 1 |
| Hyperlipidemias | 1 |
| Lung Neoplasms | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.